85 related articles for article (PubMed ID: 11431670)
1. Is the dyspnea during adenosine cardiac stress test caused by bronchospasm?
Balan KK; Critchley M
Am Heart J; 2001 Jul; 142(1):142-5. PubMed ID: 11431670
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary function monitoring during adenosine myocardial perfusion scintigraphy in patients with chronic obstructive pulmonary disease.
Johnston DL; Scanlon PD; Hodge DO; Glynn RB; Hung JC; Gibbons RJ
Mayo Clin Proc; 1999 Apr; 74(4):339-46. PubMed ID: 10221461
[TBL] [Abstract][Full Text] [Related]
3. Respiratory resistance of patients during cardiac stress testing with adenosine: is dyspnea a sign of bronchospasm?
Fricke E; Esdorn E; Kammeier A; Fricke H; Preuss R; Burchert W; Lindner O
J Nucl Cardiol; 2008; 15(1):94-9. PubMed ID: 18242485
[TBL] [Abstract][Full Text] [Related]
4. Patients with stable chronic obstructive pulmonary disease can safely undergo intravenous dipyridamole thallium-201 imaging.
Shaffer J; Simbartl L; Render ML; Snow E; Chaney C; Nishiyama H; Rauf GC; Wexler LF
Am Heart J; 1998 Aug; 136(2):307-13. PubMed ID: 9704695
[TBL] [Abstract][Full Text] [Related]
5. The pulmonary effects of intravenous adenosine in asthmatic subjects.
Burki NK; Alam M; Lee LY
Respir Res; 2006 Nov; 7(1):139. PubMed ID: 17137511
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological stress myocardial perfusion scintigraphy: use of a modified adenosine protocol in patients with asthma.
Sundram F; Notghi A; Smith NB
Nucl Med Commun; 2009 Mar; 30(3):217-25. PubMed ID: 19262284
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative bronchospasm after intravenous adenosine during general anesthesia.
Jeng CS; Huang IR; Lin CP; Lin TY; Wang MJ
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):237-40. PubMed ID: 15679135
[TBL] [Abstract][Full Text] [Related]
8. Adenosine-induced severe bronchospasm in a patient without pulmonary disease.
Coli S; Mantovani F; Ferro J; Gonzi G; Zardini M; Ardissino D
Am J Emerg Med; 2012 Nov; 30(9):2082.e3-5. PubMed ID: 22177587
[TBL] [Abstract][Full Text] [Related]
9. Does dyspnoea during dipyridamole cardiac stress testing indicate bronchospasm and is the pretest clinical history predictive of this side-effect?
Leitha T; Gwechenberger M; Falger-Banyai S
Eur J Nucl Med; 1995 Dec; 22(12):1408-10. PubMed ID: 8586086
[TBL] [Abstract][Full Text] [Related]
10. The safety and tolerability of adenosine in patients with obstructive airways disease.
van Gaal WJ; Couthino B; Chan M; Allman KC
Int J Cardiol; 2008 Aug; 128(3):436-8. PubMed ID: 17655953
[TBL] [Abstract][Full Text] [Related]
11. Incidence of acute bronchospasm during systemic adenosine administration for coronary angiography.
Morrow A; Ford TJ; Brogan R
J R Coll Physicians Edinb; 2019 Sep; 49(3):204-206. PubMed ID: 31497787
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
[TBL] [Abstract][Full Text] [Related]
13. Side effect profile and tolerability of adenosine myocardial perfusion scintigraphy in patients with mild asthma or chronic obstructive pulmonary disease.
Reyes E; Loong CY; Wechalekar K; Latus K; Anagnostopoulos C; Underwood SR
J Nucl Cardiol; 2007; 14(6):827-34. PubMed ID: 18022109
[TBL] [Abstract][Full Text] [Related]
14. Bronchospasm after intravenous administration of adenosine in a patient with asthma.
DeGroff CG; Silka MJ
J Pediatr; 1994 Nov; 125(5 Pt 1):822-3. PubMed ID: 7965442
[TBL] [Abstract][Full Text] [Related]
15. Adenosine and bronchospasm: vigilance in the electrophysiology suite.
Salter B; O'Donnell T; Weiner M; Fischer G
J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):410-1. PubMed ID: 24325956
[No Abstract] [Full Text] [Related]
16. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
17. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma.
Murray JJ; Weiler JM; Schwartz LB; Busse WW; Katial RK; Lockey RF; McFadden ER; Pixton GC; Barrett RJ
Circ Cardiovasc Imaging; 2009 Nov; 2(6):492-8. PubMed ID: 19920048
[TBL] [Abstract][Full Text] [Related]
18. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
Yetkin O; Gunen H
Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
[TBL] [Abstract][Full Text] [Related]
20. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
